Oakland, CA, United States of America

Claudio Ciferri

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Ciferri. Retrieved from https://idiyas.com/inventor/claudio-ciferri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Claudio Ciferri

Introduction: Claudio Ciferri, a talented inventor based in Oakland, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Claudio Ciferri holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced electronics, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Claudio Ciferri has worked for leading tech companies, where he spearheaded research and development projects that have resulted in cutting-edge inventions.

Collaborations: Throughout his career, Claudio Ciferri has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and pushing the boundaries of technological advancement.

Conclusion: Claudio Ciferri's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…